Pharmalis SRL
1.9 FTEPharmalis reported total assets of €1.10m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Apr 2026), with 1.9 full-time equivalent.
The score of Pharmalis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -84 % Total assets -22 % Headcount (avg FTE) -27 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmalis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Apr 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 02 Oct 2023
- Year ended 31 Dec 2021filed on 22 May 2022
Pharmalis's financial analysis
- Solvency7.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmalis
Pharmalis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.216.325
- VAT number
- BE0479216325
- Peppol
- Registered · 0208:0479216325 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jan 2003
- Registered office
- 6840 Neufchâteau
- Size
- Micro · 1.9 FTE
- Latest accounts
- 2025 · filed on 22 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmalis (SRL) has been based in Neufchâteau since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 18,272 € and equity of 85,307 €; its revenue is not published. With 1.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.8%, below the median of its sector (41.5%).
Companies similar to Pharmalis
Companies in the same business, of comparable size and area, outside its group.
- geroFarma Retail sale of pharmaceutical products Kortrijk · balance sheet €1.05m
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
- Pharma Kenis Retail sale of pharmaceutical products Geel · balance sheet €1.28m
- Apotheek De Boeck Retail sale of pharmaceutical products Lierde · balance sheet €1.30m
- Duchi-Naert Retail sale of pharmaceutical products Harelbeke · balance sheet €1.52m
- PiotFarma Retail sale of pharmaceutical products Tielt-Winge · balance sheet €1.79m
- Bayart Hensies Retail sale of pharmaceutical products Dour · balance sheet €1.14m
- Pharmakes Retail sale of pharmaceutical products Ypres · balance sheet €1.57m
Frequently asked questions about Pharmalis
What is the revenue of Pharmalis?
Pharmalis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmalis?
In Belgium, the VAT number is the company number prefixed with BE: BE0479216325 for Pharmalis, if the company is VAT-registered. Its company number (CBE) is 0479.216.325.
Where is the registered office of Pharmalis?
According to the CBE register, the registered office of Pharmalis is in 6840 Neufchâteau.
What is the equity of Pharmalis?
At the close of the 2025 financial year, the equity of Pharmalis amounts to 85,307 €, a solvency of 7.8% of total assets.
How many people work at Pharmalis?
1.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmalis?
The register lists 2 active mandates at Pharmalis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmalis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →